- Home
- WAFU vs ONVO Comparison
WAFU vs ONVO Comparison
Compare WAFU & ONVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAFU
- ONVO
- Stock Information
- Founded
- WAFU 1999
- ONVO 2007
- Country
- WAFU China
- ONVO United States
- Employees
- WAFU N/A
- ONVO N/A
- Industry
- WAFU Other Consumer Services
- ONVO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WAFU Real Estate
- ONVO Health Care
- Exchange
- WAFU Nasdaq
- ONVO Nasdaq
- Market Cap
- WAFU 7.1M
- ONVO 7.2M
- IPO Year
- WAFU 2019
- ONVO N/A
- Fundamental
- Price
- WAFU $1.69
- ONVO $0.42
- Analyst Decision
- WAFU
- ONVO
- Analyst Count
- WAFU 0
- ONVO 0
- Target Price
- WAFU N/A
- ONVO N/A
- AVG Volume (30 Days)
- WAFU 195.5K
- ONVO 102.4K
- Earning Date
- WAFU 01-01-0001
- ONVO 11-26-2024
- Dividend Yield
- WAFU N/A
- ONVO N/A
- EPS Growth
- WAFU N/A
- ONVO N/A
- EPS
- WAFU N/A
- ONVO N/A
- Revenue
- WAFU $7,223,220.00
- ONVO $103,000.00
- Revenue This Year
- WAFU N/A
- ONVO $59.08
- Revenue Next Year
- WAFU N/A
- ONVO $18.24
- P/E Ratio
- WAFU N/A
- ONVO N/A
- Revenue Growth
- WAFU N/A
- ONVO N/A
- 52 Week Low
- WAFU $1.58
- ONVO $0.32
- 52 Week High
- WAFU $2.85
- ONVO $1.74
- Technical
- Relative Strength Index (RSI)
- WAFU 45.13
- ONVO 47.62
- Support Level
- WAFU $1.58
- ONVO $0.39
- Resistance Level
- WAFU $1.83
- ONVO $0.46
- Average True Range (ATR)
- WAFU 0.10
- ONVO 0.05
- MACD
- WAFU 0.00
- ONVO -0.00
- Stochastic Oscillator
- WAFU 34.38
- ONVO 62.27
About WAFU Wah Fu Education Group Limited
Wah Fu Education Group Ltd is involved in providing online exam preparation services and related technology solutions and also produces online training course materials in China. It develops online educational materials that are offered through the cloud and that can be used for a wide range of purposes, such as standard examination preparation, professional training, and interactive programs for educational purposes other than exam preparation. Its segments are Online Education Services, and Technological Development and Operation Service. The company generates maximum revenue from the Online Education Services segment.
About ONVO Organovo Holdings Inc.
Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.